… (Pts) with previously untreated multiple myeloma without an intent for immediate … in transplant-ineligible newly diagnosed multiple myeloma: frailty subgroup analysis of … and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 …

… Despite treatment advances, patients with multiple myeloma inevitably [have] relapses, … of relapsed/refractory multiple myeloma. News release. Regeneron Pharmaceuticals … of relapsed/refractory multiple myeloma. News release. Regeneron Pharmaceuticals …

… cornerstone in the treatment of multiple myeloma (MM). Despite its proven efficacy … patients with relapsed/refractory multiple myeloma. Presented at: American Association for …

Immuno-oncology Multiple myeloma (MM) is a complex disease …

… Identify patients with high-risk multiple myeloma, satisfying the requirements of … company plans to expand beyond multiple myeloma, offering precision diagnostic products … invasive diagnostics initially focus on multiple myeloma, equipping physicians with the …

… adults with relapsed and refractory multiple myeloma. This approval targets patients who … ,000 Europeans diagnosed annually with multiple myeloma, a blood cancer that remains …

… in modulating immune surveillance in multiple myeloma.

… potentials and challenges to tackle Multiple Myeloma (MM), especially in Southeast … adult patients with newly diagnosed multiple myeloma, regardless of transplant eligibility, … the relentless quest to conquer multiple myeloma. We collaborate with medical …

… and refractory (R/R) multiple myeloma (MM). Patients eligible for the …

… Despite treatment advances, patients with multiple myeloma inevitably endure relapses, reduced responses … for relapsed/refractory multiple myeloma patients—reinforcing our relentless … most common blood cancer, multiple myeloma is newly diagnosed in …